In This Article:
As the U.S. stock market edges closer to record highs, driven by a rally in tech stocks and easing trade concerns, investors are exploring diverse opportunities across various sectors. Penny stocks, often associated with smaller or emerging companies, remain an intriguing area for those seeking potential growth at a lower entry cost. Despite their historical reputation as speculative investments, penny stocks backed by strong financials can offer unique value propositions and growth potential in today's market landscape.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Financial Health Rating |
| BAB (OTCPK:BABB) | $0.8781 | $6.23M | ★★★★★★ |
| QuantaSing Group (NasdaqGM:QSG) | $3.08 | $120.12M | ★★★★★★ |
| ZTEST Electronics (OTCPK:ZTST.F) | $0.275 | $10.3M | ★★★★★★ |
| Imperial Petroleum (NasdaqCM:IMPP) | $2.99 | $91.9M | ★★★★★★ |
| Permianville Royalty Trust (NYSE:PVL) | $1.42 | $47.19M | ★★★★★★ |
| Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $67.38M | ★★★★★★ |
| BTCS (NasdaqCM:BTCS) | $3.06 | $53.61M | ★★★★★★ |
| Smith Micro Software (NasdaqCM:SMSI) | $1.52 | $23.94M | ★★★★★☆ |
| CBAK Energy Technology (NasdaqCM:CBAT) | $0.91 | $83.05M | ★★★★★☆ |
| SideChannel (OTCPK:SDCH) | $0.03906 | $8.77M | ★★★★★★ |
Click here to see the full list of 702 stocks from our US Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
GoPro
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: GoPro, Inc. develops and sells cameras, mountable and wearable accessories, along with subscription services and software globally, with a market cap of approximately $0.15 billion.
Operations: The company's revenue is derived from its Photographic Equipment & Supplies segment, totaling $896.01 million.
Market Cap: $149.62M
GoPro, Inc. is navigating the penny stock landscape with a market cap of approximately US$0.15 billion, facing challenges due to its unprofitability and increased losses over recent years. Despite this, it has maintained a stable debt position with more cash than total debt and a reduced debt-to-equity ratio from 111.2% to 50.6% over five years. Recent product upgrades and strategic partnerships in premier racing series like MotoGP aim to enhance its brand visibility and appeal in the action camera market segment, potentially supporting future revenue streams despite current financial hurdles.
Protalix BioTherapeutics
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Protalix BioTherapeutics, Inc. is a biopharmaceutical company that develops, produces, and commercializes recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based protein expression system across various countries including the United States and Israel, with a market cap of $185.56 million.